Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Olivier Gallocher"'
Autor:
Pierre Senesse, Didier Cupissol, S. Thezenas, Christian Sire, Neck Oncology, Sandrine Lavau-Denes, Chloé Janiszewski, Hélène de Forges, Muriel Garcia-Ramirez, Olivier Gallocher, Marc Alfonsi, Lionnel Geoffrois, Marie-Christine Kaminsky, P. Boisselier
Publikováno v:
The American journal of clinical nutrition. 112(6)
Background In a previous phase II study an immunonutrient supplement was found to reduce severe acute toxicities for head and neck squamous cell cancer (HNSCC) patients treated with concomitant cisplatin and radiotherapy. Objectives The primary objec
Autor:
Michel Rives, Pascal Pommier, P. Boisselier, Enrique Chajon, David Pérol, Philippe Giraud, Lionel Perrier, Marc Alfonsi, M. Morelle, Olivier Gallocher, Etienne Bardet, Sophie Dussart, Valentin Calugaru, Georges Noël, Bernard Coche-Dequeant, J.-E. Bibault, Hinda Mecellem
Publikováno v:
Cancer Radiothérapie
Cancer Radiothérapie, Elsevier Masson, 2016, 20 (5), pp. 357-361. ⟨10.1016/j.canrad.2016.05.009⟩
Cancer Radiothérapie, Elsevier Masson, 2016, 20 (5), pp. 357-361
Cancer/Radiothérapie
Cancer/Radiothérapie, 2016, 20 (5), pp. 357-361. ⟨10.1016/j.canrad.2016.05.009⟩
Cancer Radiothérapie, Elsevier Masson, 2016, 20 (5), pp. 357-361. ⟨10.1016/j.canrad.2016.05.009⟩
Cancer Radiothérapie, Elsevier Masson, 2016, 20 (5), pp. 357-361
Cancer/Radiothérapie
Cancer/Radiothérapie, 2016, 20 (5), pp. 357-361. ⟨10.1016/j.canrad.2016.05.009⟩
Purpose Intensity-modulated radiation therapy (IMRT) has shown its interest for head and neck cancer treatment. In parallel, cetuximab has demonstrated its superiority against exclusive radiotherapy. The objective of this study was to assess the acut